Genetics Generation Advancement Corp. (TPEX:4160)
Taiwan · Delayed Price · Currency is TWD 38.90
-0.05 (-0.13%)
Oct 8, 2026, 1:12 PM CST
TPEX:4160 Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,090 | 1,329 | 1,831 | 988 | 664 | 601 | |
Market Cap Growth | -25.49% | -27.41% | 85.27% | 48.75% | 10.48% | 0.40% |
Enterprise Value | 897 | 1,017 | 1,449 | 716 | 437 | 388 |
Last Close Price | 38.90 | 47.45 | 63.22 | 33.96 | 22.57 | 20.19 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 60.92 | 62.19 | 33.47 | 34.60 | 25.82 | 76.71 |
Forward PE | - | 203.87 | 203.87 | 203.87 | 203.87 | 203.87 |
PS Ratio | 1.77 | 2.20 | 2.77 | 1.67 | 1.21 | 1.16 |
PB Ratio | 2.21 | 2.21 | 3.31 | 2.30 | 1.91 | 1.89 |
P/TBV Ratio | 2.32 | 2.30 | 3.43 | 2.42 | 2.05 | 2.06 |
P/FCF Ratio | - | - | 32.86 | 15.66 | 14.84 | - |
P/OCF Ratio | - | - | 22.43 | 14.78 | 12.82 | 82.10 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.46 | 1.69 | 2.19 | 1.21 | 0.80 | 0.75 |
EV/EBITDA Ratio | 30.98 | 40.19 | 25.33 | 28.86 | 16.38 | 216.60 |
EV/EBIT Ratio | - | 85.99 | 29.26 | 38.54 | 21.70 | - |
EV/FCF Ratio | - | - | 26.01 | 11.34 | 9.77 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.26 | 0.13 | 0.07 | 0.11 | 0.01 | 0.01 |
Debt / EBITDA Ratio | 4.35 | 2.29 | 0.62 | 1.56 | 0.09 | 1.03 |
Debt / FCF Ratio | - | - | 0.72 | 0.77 | 0.06 | - |
Net Debt / Equity Ratio | -0.39 | -0.55 | -0.67 | -0.62 | -0.73 | -0.62 |
Net Debt / EBITDA Ratio | -10.15 | -12.97 | -6.51 | -10.71 | -9.56 | -109.69 |
Net Debt / FCF Ratio | 6.23 | 7.50 | -6.68 | -4.21 | -5.70 | 313.01 |
Asset Turnover | 0.89 | 0.79 | 1.00 | 1.13 | 1.24 | 1.25 |
Inventory Turnover | 7.45 | 6.64 | 10.95 | 10.76 | 7.06 | 5.63 |
Quick Ratio | 2.15 | 2.69 | 3.06 | 2.69 | 3.37 | 2.71 |
Current Ratio | 2.50 | 3.10 | 3.32 | 2.95 | 3.76 | 3.45 |
Return on Equity (ROE) | 3.74% | 3.71% | 11.15% | 7.40% | 7.79% | 2.54% |
Return on Assets (ROA) | 0.14% | 0.97% | 4.69% | 2.21% | 2.86% | -0.68% |
Return on Invested Capital (ROIC) | 0.52% | 4.07% | 23.35% | 11.98% | 14.69% | -3.15% |
Return on Capital Employed (ROCE) | 0.30% | 1.90% | 8.90% | 4.20% | 5.80% | -1.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.65% | 1.61% | 2.99% | 2.89% | 3.87% | 1.30% |
FCF Yield | -2.85% | -3.29% | 3.04% | 6.39% | 6.74% | -0.10% |
Dividend Yield | 4.53% | - | 2.79% | 1.36% | 1.84% | 1.24% |
Payout Ratio | 274.93% | 230.70% | 23.50% | 40.54% | 27.42% | - |
Buyback Yield / Dilution | 0.32% | 0.25% | 0.01% | 0.10% | -0.41% | -0.19% |
Total Shareholder Return | 4.84% | 0.25% | 2.80% | 1.46% | 1.43% | 1.05% |